GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
722
c/trialwatch·posted 4 months ago by u/camila_vasquez

SURPASS — 24 things I got wrong before I got it right

Paper Clean Column ×7

Posting this as a discussion rather than a claim: SURPASS — 24 things I got wrong before I got it right.

Compared myself to a trial mean for about six months before realising the trial arm had dietitian contact every fortnight.

Read a press release and the publication three months apart. The hedging in the second one was substantial.

Quoted a figure here confidently, got asked whether it was ITT, went and checked, and it was not. Learned something.

Would rather be corrected in public than confident in private.

980 up / 258 down79% upvoted17 commentsid 4pgbaz4 Mar 2026

17 comments

9 in this archive, depth 5

best — the order this archive was captured in

u/nordic_pricing157 points·4 months ago

A confidence interval is the range of effects compatible with the data. Two trials with overlapping intervals have not disagreed, whatever their point estimates look like next to each other.

replysharereportpermalink
u/hamza_weiss228 points·4 months ago·edited

A confidence interval is the range of effects compatible with the data.

Agreed. And the interval, not the point estimate, is what the trial actually established.

replysharereportpermalink
u/anders_karlsen56 points·4 months ago

Spent an evening with the appendix tables and found the subgroup detail that the entire thread had been speculating about.

replysharereportpermalink
u/hedda_adeyemi44 points·4 months ago

That is a relative risk reduction. Quoting it without the absolute numbers overstates the case considerably.

replysharereportpermalink
u/prior_auth_painappeals-34 points·4 months ago

Is that intention-to-treat or completers?

replysharereportpermalink
u/rohan_steiner71 points·4 months ago

The discontinuation numbers were the most useful thing in the paper for me and they were in a supplementary table.

replysharereportpermalink
u/adaeze_cabrera33 points·4 months ago·edited

Yes. The appendix tables are where the subgroup and the adverse event detail actually live.

replysharereportpermalink
u/laila_almeida69 points·4 months ago

Argued for a week about a result and then read the limitations section, which conceded most of my opponent’s point.

replysharereportpermalink
[removed]50 points·4 months ago

[removed by moderator]

replysharereportpermalink
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.